<DOC>
	<DOCNO>NCT01765036</DOCNO>
	<brief_summary>Ductal adenocarcinoma frequent pancreatic solid lesion common tumor pancreas . Given poor prognosis major therapeutic consequence , discrimination PA pancreatic solid lesion mandatory . EUS admit sensitive imaging procedure detection characterization pancreatic tumor [ 1-3 ] . Nevertheless remain difficult differentiate , morphological feature , PA solid mass . For 15 year , endoscopic ultrasound fine needle aspiration ( EUS-FNA ) demonstrate efficiency tissue sample cyto-histologic diagnosis PA . However , negative predictive value ( NPV ) diagnosis pancreatic adenocarcinoma ( PA ) remain low ( 30-70 % ) publish prospective series [ 4 ] . So , case negative result , choice surgery follow-up remain difficult . Additional criterion get decision warrant . The assessment pancreatic tumor enhancement use ultrasound contrast agent ( UCAs ) real time image specific method seem useful improve characterization [ 4-8 ] either contrast-enhanced EUS ( CE-EUS ) , recently , contrast-enhanced harmonic EUS ( CH-EUS ) . The aim prospective multicenter study : 1. compare NPV contrast-enhanced endoscopic ultrasound ( CH-EUS ) EUS-FNA diagnosis PA ; 2. ass intra- inter-observer concordance CH-EUS diagnosis PA .</brief_summary>
	<brief_title>Contrast-harmonic Endoscopic Ultrasound ( CH-EUS ) Diagnosis Pancreatic Adenocarcinoma</brief_title>
	<detailed_description>100 patient solid pancreatic mass indeterminate origin must prospectively include 3 French center Exclusion criterion : presence cystic component great 25 % total volume lesion , pregnancy , lactation , age &lt; 18 year , usual contraindication SonoVue速 injection . All EUS procedure perform 5 experienced endosonographers follow : 1 . Conventional gray-scale B-mode conventional power Doppler EUS ass EUS characteristic pancreatic lesion ( localization , size , echogenicity , cystic component ) , aspect surround parenchyma well presence proximal duct dilation , vessel infiltration , collateral vein ; tumor node ( uTN ) staging . A systematic video 2 mode record . 2 . CH-EUS perform assess microvascularization lesion surround parenchyma : echoendoscope place front pancreatic lesion contrast-specific mode engage simultaneous monitoring fundamental B mode . A mecanical index ( MI ) 0.4 chose base previous study [ 4-6 ] . An intravenous 4.8 ml SonoVue速 bolus injection administrate antecubital vein , use 20 Gauges catheter , follow 20 ml saline flush . Examination pancreatic lesion evaluate real time video examination record store . The examination last 3 minute SonoVue速 injection ensure full examination lesion arterial ( hyper echogenicity aorta , superior mesenteric , hepatic splenic artery ) venous phase ( hyper echogenicity splenic-mesenteric-portal vessel ) . The pancreatic lesion enhancement pattern compare adjacent pancreatic parenchyma . We differentiate 3 pattern : hypo- , iso- hyperenhancement . The operator classify lesion pancreatic adenocarcinoma ( PA ) non PA. Based previous pilot study , lesion hypoenhancement consider PA lesion hyper isoenhancement non-PA [ 4-6 ] . In case tumor mix pattern lesion consider PA significant area ( &gt; 10 % surface ) hypoenhancement . 3 . EUS-FNA : specimen obtain lesion use 22 Gauge needle . Final diagnosis base pathological finding obtain either surgically EUS-FNA . In absence histological evidence , follow-up ( F-U ) patient 12 month carry . The diagnosis PA rule sign malignancy ( disease regression absence disease progression ) present end F-U . 4 . Images review : end study anonymous digital video record procedure include B mode , power Doppler mode CHE mode perform . Statistical analysis . The McNemar test use compare CH-EUS performance diagnosis PA EUS-FNA final diagnosis . Sensitivity ( Se ) , specificity ( Spe ) , predictive positive value ( PPV ) , negative predictive value ( NPV ) accuracy 95 % confidence interval ( 95 % CI ) calculate . A p value 0.05 consider statistically significant . Intra- interobserver agreement CH-EUS diagnosis PA ass use kappa statistic associate 95 % CI . Depending Kappa value , agreement consider minor ( 0.01-0.20 ) , fair ( 0.21-0.40 ) , moderate ( 0.41-0.60 ) , high ( 0.61-0.80 ) , almost perfect ( 0.81-1.00 ) , beyond chance .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>patient solid pancreatic mass indeterminate origin presence cystic component great 25 % total volume lesion , pregnancy , lactation , age &lt; 18 year , usual contraindication SonoVue速 injection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>contrast-enhanced endoscopic ultrasound</keyword>
	<keyword>pancreatic adenocarcinoma</keyword>
</DOC>